Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease

References

• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMASánchezLSTorderaMPSánchezPRSevere exacerbations and BODE index: two independent risk factors for death in male COPD patientsRespir Med2009103569269919131231
   PubMed Web of Science ®Google Scholar
• PuhanMAGarcia-AymerichJFreyMExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO indexLancet2009374969170471119716962
   PubMed Web of Science ®Google Scholar
• JonesRCDonaldsonGCChavannesNHDerivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE IndexAm J Respir Crit Care Med2009180121189119519797160
   PubMed Web of Science ®Google Scholar
• AlmagroPSorianoJBCabreraFJWorking Group on COPD, Spanish Society of Internal MedicineShort- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX indexChest2014145597298024077342
   PubMed Web of Science ®Google Scholar
• RocheNZureikMSoussanDNeukirchFPerrotinDUrgence BPCO (COPD Emergency) Scientific CommitteePredictors of outcomes in COPD exacerbation cases presenting to the emergency departmentEur Respir J200832495396118508819
   PubMed Web of Science ®Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 suppl 2398s401s10843984
   PubMed Web of Science ®Google Scholar
• CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J20072961224123817540785
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for Diagnosis, Management, and Prevention of COPD2015 Available from: http://www.goldcopd.org/Accessed January 1, 2015
   Google Scholar
• MahlerDAHarverAA factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary diseaseAm Rev Respir Dis19921452 pt 14674701736759
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyLung function testing: selection of reference values and interpretative strategiesAm Rev Respir Dis19911445120212181952453
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognositic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• HanleyJAMcNeilBJThe meaning and use of the area under a receiver operating characteristic (ROC) curveRadiology1982143129367063747
   PubMed Web of Science ®Google Scholar
• AaronSDDonaldsonGCWhitmoreGAHurstJRRamsayTWedzichaJATime course and pattern of COPD exacerbation onsetThorax201267323824322008189
   PubMed Web of Science ®Google Scholar
• LeivsethLBrumptonBMNilsenTIMaiXMJohnsenRLanghammerAGOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, NorwayThorax2013681091492123611880
   PubMed Web of Science ®Google Scholar
• DransfieldMTRoweSMJohnsonJEBaileyWCGeraldLBUse of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax200863430130517951276
   PubMed Web of Science ®Google Scholar
• ConnollyMJLoweDAnsteyKBritish Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEu)Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisationThorax2006611084384816928716
   PubMed Web of Science ®Google Scholar
• ChangCLSullivanGDKaralusNCMillsGDMcLachlanJDHancoxRJPredicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 scoreRespirology201116114615120920140
   PubMed Web of Science ®Google Scholar
• StoneRALoweDPotterJMBuckinghamRJRobertsCMPurseyNJManaging patients with COPD exacerbation: does age matter?Age Ageing201241446146822454133
   PubMed Web of Science ®Google Scholar
• MoonsKGRoystonPVergouweYGrobbeeDEAltmanDGPrognosis and prognostic research: what, why, and how?BMJ2009338b37519237405
   PubMed Web of Science ®Google Scholar
• GudmundssonGGislasonTLindbergEMortality in COPD patients discharged from hospital: the role of treatment and co-morbidityRespir Res2006710916914029
   PubMed Web of Science ®Google Scholar
• CazzolaMDi PernaFD’AmatoMCalifanoCMateraMGD’AmatoGFormoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPDRespir Med2001951191792111716207
   PubMed Web of Science ®Google Scholar
• CazzolaMMateraMGLong-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPDPulm Pharmacol Ther200316419720112850121
   PubMed Web of Science ®Google Scholar
• SegretiAFioriECalzettaLThe effect of indacaterol during an acute exacerbation of COPDPulm Pharmacol Ther201326663063423578980
   PubMed Web of Science ®Google Scholar
• MaltaisFOstinelliJBourbeauJComparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialAm J Respir Crit Care Med2002165569870311874817
   PubMed Web of Science ®Google Scholar
• GunenHHacievliyagilSSYetkinOGulbasGMutluLCInEThe role of nebulised budesonide in the treatment of exacerbations of COPDEur Respir J200729466066717251232
   PubMed Web of Science ®Google Scholar
• StällbergBSelroosOVogelmeierCAnderssonEEkströmTLarssonKBudesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre studyRespir Res2009101119228428
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar